1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer

Technology appraisal guidance [TA424] Published date: 21 December 2016

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact report PDF 323.1 KB 21 December 2016  
  • Resource impact template Excel 1.02 MB 21 December 2016  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance